Nick Devoogdt Selected Research

Broadly Neutralizing Antibodies

11/2021

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nick Devoogdt Research Topics

Disease

54	Neoplasms (Cancer) 01/2022 - 05/2003
17	Breast Neoplasms (Breast Cancer) 12/2021 - 07/2011
10	Inflammation (Inflammations) 03/2021 - 12/2012
5	Carcinoma (Carcinomatosis) 11/2019 - 07/2010
4	Multiple Myeloma 01/2022 - 12/2014
4	Neoplasm Metastasis (Metastasis) 04/2020 - 05/2003
4	Atherosclerosis 12/2019 - 01/2018
4	Atherosclerotic Plaque (Atheroma) 01/2018 - 10/2014
3	Melanoma (Melanoma, Malignant) 01/2022 - 06/2019
3	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 03/2009
3	Amyloidosis 01/2017 - 12/2016
3	Hepatitis 01/2017 - 02/2015
2	Residual Neoplasm 01/2021 - 03/2012
2	Neuroblastoma 01/2020 - 11/2017
2	Brain Neoplasms (Brain Tumor) 08/2019 - 12/2017
2	Experimental Arthritis 10/2016 - 05/2013
2	Rheumatoid Arthritis 05/2014 - 05/2013
1	COVID-19 11/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Calcinosis 10/2019
1	Triple Negative Breast Neoplasms 07/2019
1	Hemorrhage 01/2018
1	Lymphoma (Lymphomas) 12/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2017
1	Alcoholic Fatty Liver 01/2017
1	Choline Deficiency 01/2017

Drug/Important Bio-Agent (IBA)

41	Single-Domain AntibodiesIBA 01/2022 - 05/2010
14	Radioisotopes (Radionuclides)IBA 01/2022 - 03/2012
9	Biomarkers (Surrogate Marker)IBA 12/2021 - 05/2003
8	Mannose ReceptorIBA 01/2021 - 08/2012
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2010
6	AntibodiesIBA 11/2021 - 01/2013
6	N-succinimidyl 4-guanidinomethyl-3-iodobenzoateIBA 04/2020 - 04/2014
6	AntigensIBA 11/2019 - 05/2010
6	Pharmaceutical PreparationsIBA 10/2019 - 05/2014
5	Monoclonal AntibodiesIBA 01/2022 - 06/2019
5	human ERBB2 proteinIBA 01/2021 - 07/2011
5	Trastuzumab (Herceptin)FDA Link 04/2020 - 01/2013
5	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 12/2019 - 09/2016
4	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 09/2021 - 05/2013
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 10/2011
4	Secretory Leukocyte Peptidase InhibitorIBA 03/2009 - 05/2003
3	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2019
3	LigandsIBA 06/2021 - 01/2017
3	oxidized low density lipoproteinIBA 10/2019 - 10/2014
3	GelsolinIBA 01/2017 - 12/2016
2	Chelating AgentsIBA 04/2020 - 03/2012
2	LectinsIBA 10/2019 - 10/2014
2	Fluorine-18IBA 10/2019 - 01/2019
2	Biological ProductsIBA 08/2019 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 01/2017
2	GoldIBA 01/2017 - 06/2011
2	Concanavalin AIBA 01/2017 - 02/2015
2	Peptide Hydrolases (Proteases)FDA Link 03/2009 - 05/2003
2	Protease Inhibitors (Protease Inhibitor)IBA 03/2009 - 05/2003
1	ParaproteinsIBA 01/2022
1	OvalbuminIBA 01/2022
1	Lutetium-177IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	CalreticulinIBA 01/2022
1	RadiopharmaceuticalsIBA 12/2021
1	Broadly Neutralizing AntibodiesIBA 11/2021
1	avelumabIBA 09/2021
1	ConnexinsIBA 03/2021
1	Actinium-225IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Pentetic Acid (DTPA)FDA LinkGeneric 04/2020
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2020
1	AcidsIBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	N-chlorosuccinimideIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019
1	Surface Antigens (Surface Antigen)IBA 11/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2019
1	Gallium-68IBA 10/2019
1	FluoridesIBA 10/2019
1	VaccinesIBA 08/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2019
1	AlbuminsIBA 10/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Rituximab (Mabthera)FDA Link 12/2017
1	EpitopesIBA 12/2017
1	pertuzumabIBA 12/2017
1	Insulin (Novolin)FDA Link 11/2017
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	CholesterolIBA 01/2017
1	LDL CholesterolIBA 01/2017
1	C-Type Lectins (C-Type Lectin)IBA 01/2017

Therapy/Procedure

30	Therapeutics 01/2022 - 10/2011
8	Precision Medicine 01/2022 - 12/2014
3	Radioimmunotherapy 11/2019 - 03/2012
3	Intravenous Injections 06/2019 - 07/2011
1	Computer-Assisted Surgery (Image Guided Surgery) 01/2022
1	Radiotherapy 01/2020
1	Microbubbles 12/2019
1	Immunotherapy 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018
1	Intravenous Administration 12/2017